The REACH Regulation in the Pharmaceutical Environment
As a pharmaceutical company, Midas Pharma is involved in the production and supply chain of pharmaceuticals on a daily basis. Sometimes hazardous substances are used in the production processes for these drugs, which are harmful to humans and the environment.
Chemicals should generally be produced and used in such a way that negative effects on humans and the environment are kept to a minimum.
With a fundamental reform and standardization of the European chemicals law, the REACH regulation came into force on June 1, 2007. Its aim is to generate and collect information on chemicals with regard to their effects on humans and the environment and to improve the protection of human health and the environment from the risks that can arise from chemicals.
REACH stands for Registration, Evaluation, Authorization of Chemicals. Registration is mandatory for manufacturers and importers, who have to register all substances or mixtures that are manufactured or imported in quantities of one ton or more per year with the European Chemicals Agency (ECHA).
The basic principle is: "No Data, no Market".
This means that a non-registered substance may neither be manufactured nor imported.
REACH at Midas: Added value for our customers
Midas Pharma complies with the obligations regarding the registration of pharmaceutical intermediates and chemicals according to REACH. Thus, a number of different substances have already been registered to ensure a REACH compliant supply of our customers.
Therefore, a registration by our customers is not necessary, which is another aspect of our added value concept.
In this context Midas Pharma provides the required Material Safety Data Sheet (MSDS) in the respective national language of our customers as an elementary part of risk prevention and as required by the REACH regulation. As a result, the dangers implied by a chemical can be assessed by everyone and appropriate safety precautions can be taken.